Ironwood Pharmaceuticals, Inc. (IRWD)
4.50
-0.02
(-0.44%)
USD |
NASDAQ |
Jan 16, 16:00
4.45
-0.05
(-1.11%)
After-Hours: 20:00
Ironwood Pharmaceuticals Shareholders Equity (Quarterly): -264.16M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -2.642B |
| Outlook Therapeutics, Inc. | -37.19M |
| Nektar Therapeutics | 85.09M |
| Rigel Pharmaceuticals, Inc. | 117.61M |
| CorMedix, Inc. | 374.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 396.06M |
| Total Liabilities (Quarterly) | 660.22M |
| Debt to Equity Ratio | -2.265 |
| Current Ratio | 1.129 |
| Net Debt Paydown Yield | 3.94% |